BBM-P002
/ Xiangya Hospital Central South University, Belief Biomed
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 30, 2025
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Shanghai Xinzhi BioMed Co., Ltd.
New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 1
Of
1
Go to page
1